Clinical Trial Update: Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lapatinib versus placebo with cisplatin and radiotherapy in unresected head and neck cancer has completed enrollment and posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Lapatinib (Lapatinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms, Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2015-01-05